Show simple item record

dc.contributor.authorTauschmann, Martinen
dc.contributor.authorThabit, Hen
dc.contributor.authorLeelarathna, Len
dc.contributor.authorElleri, Danielaen
dc.contributor.authorAllen, Janeten
dc.contributor.authorLubina-Solomon, Aen
dc.contributor.authorStadler, Men
dc.contributor.authorWalkinshaw, Een
dc.contributor.authorIqbal, Aen
dc.contributor.authorChoudhary, Pen
dc.contributor.authorWilinska, Malgorzataen
dc.contributor.authorHeller, SRen
dc.contributor.authorAmiel, SAen
dc.contributor.authorEvans, Marken
dc.contributor.authorDunger, Daviden
dc.contributor.authorHovorka, Romanen
dc.date.accessioned2015-10-21T14:04:56Z
dc.date.available2015-10-21T14:04:56Z
dc.date.issued2015-10-07en
dc.identifier.citationJournal of Diabetes Science and Technology 2015, 9(6): 1346-1347. doi:10.1177/1932296815604439en
dc.identifier.issn1932-2968
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/252353
dc.description.abstractUnsupervised free-living overnight home use of closed-loop insulin delivery is feasible, safe, and effective in adolescents1 and adults2 with type 1 diabetes, but outcomes vary between individuals. Understanding factors influencing glucose outcomes may help to identify vulnerable populations, guide design of future studies, and lead to enhanced control algorithms.
dc.description.sponsorshipFunding for these studies was received from the JDRF (#22-2009-802) and Diabetes UK (BDA07/0003549), with additional support for the Artificial Pancreas work by National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK085621), Wellcome Strategic Award (100574/Z/12/Z), and National Institute for Health Research Cambridge Biomedical Research Centre.
dc.languageengen
dc.language.isoenen
dc.publisherSAGE Publications
dc.rightsCreative Commons Attribution 4.0 International License
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectclosed-loop insulin deliveryen
dc.subjectglycemic controlen
dc.subjecthome studyen
dc.subjectpredictive factorsen
dc.subjecttype 1 diabetesen
dc.subjectAdolescenten
dc.subjectAdulten
dc.subjectAge Factorsen
dc.subjectBiomarkersen
dc.subjectBlood Glucoseen
dc.subjectDiabetes Mellitus, Type 1en
dc.subjectHemoglobin A, Glycosylateden
dc.subjectHumansen
dc.subjectHypoglycemiaen
dc.subjectHypoglycemic Agentsen
dc.subjectInsulinen
dc.subjectInsulin Infusion Systemsen
dc.subjectLinear Modelsen
dc.subjectRandomized Controlled Trials as Topicen
dc.subjectRisk Factorsen
dc.subjectTime Factorsen
dc.subjectTreatment Outcomeen
dc.titleFactors Associated With Glycemic Control During Free-Living Overnight Closed-Loop Insulin Delivery in Children and Adults With Type 1 Diabetes.en
dc.typeArticle
prism.endingPage1347
prism.issueIdentifier6en
prism.publicationDate2015en
prism.publicationNameJournal of Diabetes Science and Technologyen
prism.startingPage1346
prism.volume9en
dc.rioxxterms.funderWellcome Trust
dcterms.dateAccepted2015-08-15en
rioxxterms.versionofrecord10.1177/1932296815604439en
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by/4.0/en
rioxxterms.licenseref.startdate2015-10-07en
dc.contributor.orcidTauschmann, Martin [0000-0002-2305-2490]
dc.contributor.orcidWilinska, Malgorzata [0000-0003-2739-1753]
dc.contributor.orcidEvans, Mark [0000-0001-8122-8987]
dc.contributor.orcidDunger, David [0000-0002-2566-9304]
dc.contributor.orcidHovorka, Roman [0000-0003-2901-461X]
dc.identifier.eissn1932-2968
rioxxterms.typeJournal Article/Reviewen
pubs.funder-project-idCambridge University Hospitals NHS Foundation Trust (CUH) (Roman Hovorka)
pubs.funder-project-idNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (R01DK085621)
pubs.funder-project-idWellcome Trust (100574/Z/12/Z)
cam.issuedOnline2015-11-11en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution 4.0 International License
Except where otherwise noted, this item's licence is described as Creative Commons Attribution 4.0 International License